You are here
Home 🌿 Medical Cannabis News 🌿 Liberal MPs vote to maintain excise tax on medical cannabis despite pushback from patients 🌿Liberal MPs vote to maintain excise tax on medical cannabis despite pushback from patients

Liberal members of the finance committee have voted against an amendment that could have led to the exemption of medical cannabis from Bill C-74’s proposed excise tax.
"Perhaps 4,000 or more Canadians have written to the members of this committee to oppose this new system, this tax regime on cannabis for medical purposes," said MP Pierre Luc Dusseault of the NDP in the House of Commons yesterday (May 22), as the committee conducted a clause-by-clause review of the bill.
"It will have a very negative effect on current users because it's a system that is already in place. More than 260,000 people are using cannabis for medical purposes, and they have openly criticized this new tax on their medication."
Dusseault first proposed that the bill be amended so that the definition of medical cannabis be expanded to include medical cannabis products that do not have a drug identification number. If passed, he hoped that amendment would set the stage for a second that would have seen members vote on whether or not medical cannabis should be exempted from the excise tax.
"[The tax] is okay for cannabis destined for recreational purposes, but here we are speaking about cannabis for medical purposes," Dusseault said in his address to the house.
"We have heard from many civil societies, and several colleagues around the table would like to see a tax exemption for medical purposes."
In her attempt to refute his points, Liberal MP Jennifer O'Connell said that the excise tax would not apply to cannabis-based products with a DIN. (Currently, just three drugs containing synthetic cannabinoids have been issued DINs: Nabilone, Cesamet, and Sativex.)
"The excise duty does not apply to products that have DIN numbers, or that are prescribed by a physician," she said. "I think that's an important clarification, because, for example, under the current system, doctors provide authorization, not a prescription for medical cannabis."
O'Connell added that going through the "rigorous process" required for a prescription drug to receive a DIN number is something that Canadians have come to expect, and noted that if other cannabis products would one day receive DIN numbers, the legislation to exempt such products from the tax would already be in place.
"I'm happy that there's a path to get there, but it's up to those cannabis producers to go through the rigorous testing all Canadians would expect,” she said.
The amendment was defeated, with five Liberal MPs voting against it while Conservative and NDP MPs were in support.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.